摘要
目的 :评价肺病专用低糖类营养配方 (益菲佳 )对呼吸衰竭病人的影响。 方法 :将 6 0例符合入选标准的病人随机分为研究组和对照组 ,研究组给予益菲佳 ,对照组给予均衡经肠营养制剂 (安素 )。于治疗前后分别检测病人的血脂、血清蛋白质和二氧化碳分压 (PaCO2 )、氧分压 (PaO2 )、氧耗量 (VO2 )、二氧化碳生成量 (VCO2 )和呼吸商 (RQ)等指标 ,以评价其营养支持效果。 结果 :经过 1 0天的营养治疗 ,研究组的血气分析指标与治疗前相比有显著性差异 (P <O .0 5或P <0 .0 1 ) ,而且与对照组同期相比也有显著性差异 (P <0 .0 5或P <0 .0 1 )。 结论 :益菲佳能降低机械通气病人的VO2 、VCO2 、PaCO2 和RQ ,对改善呼吸衰竭病人的肺功能和营养状态具有一定的作用。
Objective: To evaluate the effect of nutritional support with low carbohydrate formula (Pulmocare, Abbott, America) in patients with pulmenary disease and respiratory failure. Methods: 60 patients were randomly divided into control group and study group. The study group was given Pulmocare and the control group was given Ensure (standard enteral nutrition,Abbott, America). The lipidemia, serum protein, PaCO 2 ,PaO 2 ,VO 2 ,VCO 2 and RQ were measured before and after therapy. Results: The patients' nutritional status of the two groups was improved significantly. The index of artery blood gas analysis was significantly improved( P <0.05 or P <0.01) in study group when compared with pre therapy. There was significant difference in VO 2 , VCO 2 and RQ between groups ( P <0.05 or P <0.01). Conclusions: Pulmocare can decrease the VO 2 , VCO 2 , PaCO 2 and RQ and improve nutritional status in patients with pulmonary disease and respiratory failure.
出处
《肠外与肠内营养》
CAS
2004年第4期202-204,共3页
Parenteral & Enteral Nutrition
